Medicine guide

Synflorix

Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.

What it is for

Active immunisation against invasive disease and acute otitis media caused by Streptococcus pneumoniae in infants and children from six weeks up to five years of age. See sections 4.4 and 5.1 in product information for information on protection against specific pneumococcal serotypes. The use of Synflorix should be determined on the basis of official recommendations taking into consideration the impact of invasive disease in different age groups as well as the variability of serotype epidemiology in different geographical areas.

From the official label · 2026-09-30 · European Medicines Agency

Made by	GlaxoSmithKline Biologicals S.A.
Active substance	Pneumococcal polysaccharide conjugate vaccine (adsorbed)
Used in	Antibiotics, antivirals and antifungals taken into the body
Classification	J07AL52 · Antibiotics, antivirals and antifungals taken into the body
Authorised on	2009-03-29
Last updated by the regulator	2026-05-19
EMA product number	EMEA/H/C/000973

Source: European Medicines Agency — medicine data · 2026-09-30 · not reviewed by a clinician

Source: European Medicines Agency (EMA). Product information as published by EMA. Reuse terms: EMA legal notice (reproduction authorised).

These contain the same substance. That does not mean one can replace another — ask a pharmacist.